These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12837804)

  • 21. Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA.
    Novotny GW; Jakobsen L; Andersen NM; Poehlsgaard J; Douthwaite S
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3677-83. PubMed ID: 15388419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations.
    Farrell DJ; Morrissey I; Bakker S; Buckridge S; Felmingham D
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3169-71. PubMed ID: 15273142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
    Bemer-Melchior P; Juvin ME; Tassin S; Bryskier A; Schito GC; Drugeon HB
    Antimicrob Agents Chemother; 2000 Nov; 44(11):2999-3002. PubMed ID: 11036012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent developments on ketolides and macrolides.
    Wu YJ; Su WG
    Curr Med Chem; 2001 Dec; 8(14):1727-58. PubMed ID: 11562291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships of ketolides vs. macrolides.
    Douthwaite S
    Clin Microbiol Infect; 2001; 7 Suppl 3():11-7. PubMed ID: 11523556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
    Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
    Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct mode of interaction of a novel ketolide antibiotic that displays enhanced antimicrobial activity.
    Kouvela EC; Kalpaxis DL; Wilson DN; Dinos GP
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1411-9. PubMed ID: 19164155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ketolides: a critical review.
    Zhanel GG; Walters M; Noreddin A; Vercaigne LM; Wierzbowski A; Embil JM; Gin AS; Douthwaite S; Hoban DJ
    Drugs; 2002; 62(12):1771-804. PubMed ID: 12149046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK.
    Johnson AP; Henwood CJ; Tysall L; Warner M
    Int J Antimicrob Agents; 2001 Jul; 18(1):73-6. PubMed ID: 11463530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The structure of ribosome-lankacidin complex reveals ribosomal sites for synergistic antibiotics.
    Auerbach T; Mermershtain I; Davidovich C; Bashan A; Belousoff M; Wekselman I; Zimmerman E; Xiong L; Klepacki D; Arakawa K; Kinashi H; Mankin AS; Yonath A
    Proc Natl Acad Sci U S A; 2010 Feb; 107(5):1983-8. PubMed ID: 20080686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An examination of the differential sensitivity to ketolide antibiotics in ermB strains of Streptococcus pyogenes and Streptococcus pneumoniae.
    Champney WS; Mentens N; Zurawick K
    Curr Microbiol; 2004 Oct; 49(4):239-47. PubMed ID: 15386111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
    Reinert RR; Al-Lahham A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci.
    Barry AL; Fuchs PC; Brown SD
    Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):494-7. PubMed ID: 11561807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A crevice adjoining the ribosome tunnel: hints for cotranslational folding.
    Amit M; Berisio R; Baram D; Harms J; Bashan A; Yonath A
    FEBS Lett; 2005 Jun; 579(15):3207-13. PubMed ID: 15943964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketolides-telithromycin, an example of a new class of antibacterial agents.
    Bryskier A
    Clin Microbiol Infect; 2000 Dec; 6(12):661-9. PubMed ID: 11284926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into the mode of action of novel fluoroketolides, potent inhibitors of bacterial protein synthesis.
    Krokidis MG; Márquez V; Wilson DN; Kalpaxis DL; Dinos GP
    Antimicrob Agents Chemother; 2014; 58(1):472-80. PubMed ID: 24189263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin.
    Weiss K; Guilbault C; Cortes L; Restieri C; Low DE;
    J Antimicrob Chemother; 2002 Sep; 50(3):403-6. PubMed ID: 12205066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
    Walsh F; Willcock J; Amyes S
    J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and mechanistic basis for translation inhibition by macrolide and ketolide antibiotics.
    Beckert B; Leroy EC; Sothiselvam S; Bock LV; Svetlov MS; Graf M; Arenz S; Abdelshahid M; Seip B; Grubmüller H; Mankin AS; Innis CA; Vázquez-Laslop N; Wilson DN
    Nat Commun; 2021 Jul; 12(1):4466. PubMed ID: 34294725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Ribosomal Protein uL22 Modulates the Shape of the Protein Exit Tunnel.
    Wekselman I; Zimmerman E; Davidovich C; Belousoff M; Matzov D; Krupkin M; Rozenberg H; Bashan A; Friedlander G; Kjeldgaard J; Ingmer H; Lindahl L; Zengel JM; Yonath A
    Structure; 2017 Aug; 25(8):1233-1241.e3. PubMed ID: 28689968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.